Product NDC: | 55390-560 |
Proprietary Name: | Dobutamine |
Non Proprietary Name: | Dobutamine hydrochloride |
Active Ingredient(s): | 12.5 mg/mL & nbsp; Dobutamine hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-560 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074277 |
Marketing Category: | ANDA |
Start Marketing Date: | 19950102 |
Package NDC: | 55390-560-90 |
Package Description: | 10 VIAL in 1 BOX (55390-560-90) > 20 mL in 1 VIAL |
NDC Code | 55390-560-90 |
Proprietary Name | Dobutamine |
Package Description | 10 VIAL in 1 BOX (55390-560-90) > 20 mL in 1 VIAL |
Product NDC | 55390-560 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Dobutamine hydrochloride |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19950102 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | DOBUTAMINE HYDROCHLORIDE |
Strength Number | 12.5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC] |